BiotechTube
Home/EvlaBio/Wenzel von der Heydte
WV

Wenzel von der Heydte

CEO & Co-founder

EvlaBio

Therapeutic Areas

Cardiorenal DiseaseChronic Kidney DiseaseCardiovascular Disease

EvlaBio Pipeline

DrugIndicationPhase
Anti-FGFR4 mAbLeft Ventricular Hypertrophy in Chronic Kidney DiseasePre-clinical

Leadership Team at EvlaBio

CS
Christian Stegmann
CSO
TK
Thomas Kirmeier
COO & Co-founder
View full EvlaBio profile